Industrial Hemp Biotech’s Mission Conveyed Through the Eyes of Renowned Director and Artist
NEW YORK (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (AXIM), a leader in industrial hemp biosciences, is proud to announce the launch of its new website at www.AXIMbiotech.com. The industrial hemp biotech’s website is designed by Andre Weinfeld, a renowned Producer, Writer, Director, Journalist and Photographer.
Weinfeld’s career highlights include directing and producing films – including his screenplay “La Cle Sur la Porte” and London Film Festival award winner “La Bonne Nouvelle” – to reporting TV news. His coverage includes historic events such as the Monterey International Pop and Woodstock Festivals. His stories captured the likes of: Jimi Hendrix, The Beatles, The Rolling Stones, Cream, Jim Morrison & The Doors, The Who, Janis Joplin, Otis Redding, Donovan, Eric Clapton, Steve Winwood, The Moody Blues, and Pink Floyd. Also a TV War Correspondent and Special Envoy, Weinfeld traveled around the world by pursuing “hard news” assignments. Weinfeld’s inherent talent is creating narrative while drawing emotion from viewers and creating an experience that leaves an indelible impression.
“AXIM’s new website is immaculate and it clearly depicts the resurgence of a vibrant and thriving global industrial hemp industry,” states Dr. George E. Anastassov, MD, DDS, MBA and CEO of AXIM Biotech. “We are extremely proud of the first online impression that AXIM’s website visitors will receive. AXIM’s ongoing mission of research and development of hemp-based solutions for conditions with no known cure is extremely serious – yet full of possibilities and hope. Mr. Weinfeld’s creative artistry visually captures this. Through our website, we feel that AXIM has achieved its goal of setting the ‘green standard’ in the industrial hemp industry.”
Throughout Andre Weinfeld’s career in photography, motion pictures and journalism, he has evolved his craft into an art form. Making the move from creating traditional media content to multimedia content marketing was a natural progression.
“Websites are a new contemporary art form,” states Andre Weinfeld. “This online platform is multi-generational and collaborative on a global scale. It allows artists the creative freedom and limitless potential to convey what is new, innovative and unique. To me, corporate websites should be beautiful, emotional and engaging. I enjoy designing them and look forward to creating more.”
When asked about where he found the inspiration for creating a captivating multimedia website for an industrial hemp biotech, Weinfeld states, “Dr. Anastassov’s passion and enthusiasm for hemp biosciences and appreciation for fine art inspired me to create a unique image for AXIM. Creatively, the website had to express that AXIM is a visionary Company that is leading efforts in the global hemp biosciences industry.”
Weinfeld concludes, “I also believe in second chances. Cannabis is a powerful botanical that has come full-circle; it deserves a second chance.”
Harnessing the power of industrial hemp is the foundation of AXIM Biotech’s business plan, which aims to use the natural plant to benefit human health, while providing clean alternative energy and delivering many other innovative applications. By focusing efforts on unique proprietary delivery mechanisms for the introduction of cannabinoids (e.g. CBD, CBG, etc.), AXIM Biotech is charting a course to develop solutions for conditions for which there is currently no effective treatment. The Company’s plans would leave a net negative carbon footprint on the environment in the process.
AXIM Biotech also creates strategic partnerships and acquisitions, allowing ongoing research and development in the areas of functional foods, nutraceuticals, pharmaceuticals, cosmetics, and clean energy — all derived from the industrial hemp plant.
AXIM Biotech has been featured by media outlets including: FOX Business, CRAINS New York, MainStreet.com, MJ Freeway, Chemical & Engineering News, Dental Tribune, Pharmaceutical Commerce, Dental Products Report and MJI News. For more information, visit AXIM Biotech’s website.
Andre Weinfeld can be contacted at [email protected]
To arrange for media interviews, contact Andrew Hard, Public Relations Spokesperson, at [email protected] or call 858-380-5478.
AXIM Biotechnologies, Inc. (AXIM) is an innovative biotechnology Company focusing on research, development and production of pharmaceutical, nutraceutical and cosmetic products where we prioritize the well-being of our customers while embracing a solid fiscal strategy. For more information, visit the Company website at www.AXIMBiotech.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Axim Biotechnologies, Inc. to be materially different from the statements made herein.
AXIM Biotechnologies does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell, and distribute hemp-based products.
North American Address: 18 East 50th Street, 5 Floor New York, NY 10022 +1 844 294 6246 European Address: Boelewerf 32, Unit 3 2987 VD Ridderkerk, The Netherlands +31 10 8209 227